A valuable resource for undergraduates and graduates providing a thorough grounding in the scientific basis and clinical application of antimicrobial drugs. The new edition has been thoroughly updated to include the most recently licensed agents, including the treatment of HIV and contains guidance on prescribing and infection control practices.
A valuable resource for undergraduates and graduates providing a thorough grounding in the scientific basis and clinical application of antimicrobial drugs. The new edition has been thoroughly updated to include the most recently licensed agents, including the treatment of HIV and contains guidance on prescribing and infection control practices.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Peter Davey has over thirty years experience of research focused on the outcomes of antimicrobial chemotherapy and the relationships between prescribing and resistance. He trained as an Infectious Diseases Physician in Birmingham UK and at the Tufts New England Medical Centre in Boston. He was the first Director of the University of Dundee's Health Informatics Centre from 2003-6. He is past President of the International Society for Pharmacoeconomics and Outcomes Research and of the British Society for Antimicrobial Chemotherapy. He is Surveillance and Stewardship Secretary of the British Society for Antimicrobial Chemotherapy. Mark Wilcox is a Consultant and Clinical Director of Microbiology and Pathology at Leeds Teaching Hospitals NHS Trust. His is also Professor of Medical Microbiology, University of Leeds, UK Will Irving qualified in Medicine from Cambridge, and completed a PhD in Immunology, before specializing in Virology .Will's main interest is in viral hepatitis. He chairs the Department of Health Advisory Group on Hepatitis, and is co-chair of HCV Research UK (a national cohort of patients with hepatitis C virus infection). Will is also a keen bridge player, and avid Leeds Rhinos and Utd fan. Guy Thomas qualified from Cambridge University and the United Medical and Dental schools of Guy's and St Thomas' and trained in Infectious Diseases and Microbiology in Brighton, the Oxford University Clinical Research Unit (OUCRU) in Vietnam, Imperial College London, and the Hospital for Tropical Diseases in London. Guy held Wellcome Trust Training and Intermediate Fellowships to study tuberculosis; and is a founder and Chairman of the UK Clinical Infection Research Group. Between 2011 and 2013 he was a Reader in Infectious Diseases at King's College London and Honorary Consultant in Infectious Diseases and Clinical Microbiology at Guy's and St. Thomas' NHS Foundation trust, before returning to Vietnam in 2013 to take over as Director of OUCRU.
Inhaltsangabe
* Part 1: General properties of antimicrobial agents * 1: Mechanisms of action and resistance to modern antibacterial with a history of their development * 2: Inhibitors of bacterial cell wall synthesis * 3: Inhibitors of bacterial protein synthesis * 4: Synthetic antibacterial agents and miscellaneous antibiotics * 5: Antiviral agents * 6: Antiretroviral agents * 7: Drugs used in the treatment of viral hepatitis * 8: Antifungal agents * 9: Antiprotozoal and anthelminthic agents * Part 2: Resistance to antimicrobial agents * 10: The problem of resistance * 11: The genetics and mechanisms of acquired resistance * Part 3: General principles of usage of antimicrobial agents * 12: Laboratory investigations and the treatment of infection * 13: General principles of the treatment of infection * 14: Pharmacokinetic and pharmacodynamics principles * 15: Prescribing in special groups: effects of age, pregnancy, body weight, hepatic and renal impairment * 16: Outpatient parenteral antimicrobial therapy * 17: Adverse drug reactions and patient safety * 18: Chemoprophylaxis and immunisation * 19: Guidelines, formularies, and antimicrobial policies * 20: Antimicrobial stewardship, surveillance of antimicrobial consumption and its consequences * Part 4: Therapeutic use of antimicrobial agents * 21: Respiratory tract infections * 22: Topical use of antimicrobial agents * 23: Urinary tract infections * 24: Sexually transmitted infections * 25: Gastrointestinal infections * 26: Serious bacterial bloodstream infections * 27: Bone and joint infections * 28: Infections of the central nervous system * 29: Skin and soft tissue infections * 30: Tuberculosis and other mycobacterial diseases * 31: Infections in immunocompromised patients including HIV/AIDs * 32: Viral infections * 33: Management of HIV infection * 34: Treatment of chronic viral hepatitis * 35: Parasitic disease * 36: The development and marketing of antimicrobial drugs * Appendix 1: Further Reading
* Part 1: General properties of antimicrobial agents * 1: Mechanisms of action and resistance to modern antibacterial with a history of their development * 2: Inhibitors of bacterial cell wall synthesis * 3: Inhibitors of bacterial protein synthesis * 4: Synthetic antibacterial agents and miscellaneous antibiotics * 5: Antiviral agents * 6: Antiretroviral agents * 7: Drugs used in the treatment of viral hepatitis * 8: Antifungal agents * 9: Antiprotozoal and anthelminthic agents * Part 2: Resistance to antimicrobial agents * 10: The problem of resistance * 11: The genetics and mechanisms of acquired resistance * Part 3: General principles of usage of antimicrobial agents * 12: Laboratory investigations and the treatment of infection * 13: General principles of the treatment of infection * 14: Pharmacokinetic and pharmacodynamics principles * 15: Prescribing in special groups: effects of age, pregnancy, body weight, hepatic and renal impairment * 16: Outpatient parenteral antimicrobial therapy * 17: Adverse drug reactions and patient safety * 18: Chemoprophylaxis and immunisation * 19: Guidelines, formularies, and antimicrobial policies * 20: Antimicrobial stewardship, surveillance of antimicrobial consumption and its consequences * Part 4: Therapeutic use of antimicrobial agents * 21: Respiratory tract infections * 22: Topical use of antimicrobial agents * 23: Urinary tract infections * 24: Sexually transmitted infections * 25: Gastrointestinal infections * 26: Serious bacterial bloodstream infections * 27: Bone and joint infections * 28: Infections of the central nervous system * 29: Skin and soft tissue infections * 30: Tuberculosis and other mycobacterial diseases * 31: Infections in immunocompromised patients including HIV/AIDs * 32: Viral infections * 33: Management of HIV infection * 34: Treatment of chronic viral hepatitis * 35: Parasitic disease * 36: The development and marketing of antimicrobial drugs * Appendix 1: Further Reading
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
